Doctors at a hospital here have used a new drug called RLF-100, also known as aviptadil, that has led to rapid recovery from respiratory failure in critically ill COVID-19 patients. The drug has been approved by the FDA for emergency use at multiple clinical sites in patients who are too ill to enter the FDA's Phase 2/3 trials.
At least 8 patients lost their lives after a massive fire erupted at a hospital in Gujarat's Ahmedabad. According to the details, the blaze was reported from Navrangpura's Shrey Hospital.
At least 90 percent of a sample group of COVID-19 recovered patients in China's Wuhan city have reported lung damage, according to a media report. Five percent of them are again in quarantine after testing positive for the virus.
The drug tocilizumab, which is used in the treatment of various forms of arthritis, can greatly shorten the time on ventilation and hospital stays for patients with severe COVID-19, according to a Swedish study.
A video, which shows three persons boarding the trolley in Nellimarla town, has gone viral on social media, prompting the authorities to order a probe.
A 28-year-old doctor from Karnataka's Ballari district has celebrated his birthday with coronavirus patients to cheer them up as most of them are gloomy in isolation, said an official on Monday.
About 2,300 people, who tested positive for COVID-19 here, had given false information pertaining to their names, mobile numbers and addresses, a health official said on Monday. While 1,171 people out of those who gave false information have been tracked, a hunt is on for the others.
The Goa government on Sunday said that plasma therapy treatment for critical patients of COVID-19 has begun in the state.
The ICMR in collaboration with the Health Ministry and the AIIMS is planning to set up the National Clinical Registry which will help researchers and policy makers understand effectiveness of investigational therapies, adverse effects taking place and generate evidence for improving the treatment of COVID-19 patients.
The deceased was identified as Shaym Kumar Sahu and was a resident of Jharia in Dhanbad. According to media reports, Sahu was brought to the hospital after he was diagnosed with coronavirus. The patient was put on oxygen support at the hospital after he had complained of breathing problems.
The pregnant woman was taken to three hospitals in about 36 hours since Tuesday but all of them refused to treat her.
A 105-year-old woman, Asma Beevi on Wednesday was cured of Covid-19 disease and was discharged from the hospital.
A 40-year-old man, who had tested coronavirus positive, allegedly committed suicide at a COVID-19 facility in Madhya Pradesh's Chhatarpur, policesaid on Wednesday.
Canada has announced its authorisation for using the drug remdesivir for treating patients suffering severe symptoms of Covid-19 who have pneumonia and require extra oxygen to help them breathe.
A 20-year-old woman here alleged that she was molested by a doctor in the isolation ward of a private hospital where both were undergoing treatment for COVID-19, police said on Monday.
Besides, for the first time a record number of more than 4,40,000 tests have been conducted in a single day.
The two brothers -- one nine-month-old and the other nine-and-half-years -- both undergoing treatment at the Institute of Child Health (ICH), tested positive for COVID-19 on Friday, after which their father tried hiring an ambulance to take them to a state-run hospital.
This is the second suicide case in the premier hospital involving a coronavirus infected patient in just over a month.
Delhi's coronavirus situation is improving by the day. In what might be a ray of hope not just for the national capital but the whole nation, the hospitalized patients in Delhi have dropped to 4,878. This is a drastic drop from a month or so ago when Delhi was starring at a grim situation and shortage of beds for coronavirus patients.
Pharmaceutical firm Cipla is set to launch COVID-19 drug Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process. Cipla has scaled up the process in their manufacturing facility and approached DCGI (Drug Controller General of India) for permission to launch the product in India.
Top News
Latest News
